e-learning
resources
European Respiratory Review
2018
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The consequence of matrix dysfunction on lung immunity and the microbiome in COPD
Tracy Hussell, Sylvia Lui, Christopher Jagger, David Morgan, Oliver Brand
Source:
Eur Respir Rev, 27 (148) 180032; 10.1183/16000617.0032-2018
Journal Issue:
June
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Tracy Hussell, Sylvia Lui, Christopher Jagger, David Morgan, Oliver Brand. The consequence of matrix dysfunction on lung immunity and the microbiome in COPD. Eur Respir Rev, 27 (148) 180032; 10.1183/16000617.0032-2018
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
The longitudinal relationship between bacterial load airway inflammation and lung function decline in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 212s
Year: 2002
The microbiome in interstitial lung disease
Source: Lung Science Conference 2015
Year: 2015
The consequences of microbiome and pathogen dynamics for chronic lung diseases
Source: Annual Congress 2012 - The bacterial microbiota: implications for health and disease - joint session with the World Allergy Organisation
Year: 2012
Local immune protection mechanisms during bacterial infection of the airways in patients with interstitial lung diseases
Source: Annual Congress 2009 - Mechanisms of infection: what's new?
Year: 2009
Influence of bacteria from the COPD lung microbiome on cigarette smoke-induced pro-inflammatory responses of three-dimensional lung epithelial cell cultures
Source: International Congress 2018 – The airway microbiome across the spectrum of airway disease
Year: 2018
The pulmonary microbiome and immunological activity in IPF patients.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020
The lung microbiome in obstructive airways disease: potential pathogenetic roles
Source: Eur Respir Monogr 2019; 83: 140-157
Year: 2019
The nature of inflammation and tissue damage in COPD
Source: Annual Congress 2004 - Acquired somatic mutations in the pathogenesis of COPD
Year: 2004
Decreasing of lung function in patients with chronically obstructive lung diseases as effect of damage of bronchial mucosa cilia
Source: Eur Respir J 2003; 22: Suppl. 45, 416s
Year: 2003
The innate immune function of airway epithelial cells in inflammatory lung disease
Source: Eur Respir J 2015; 45: 1150-1162
Year: 2015
Why does chronic bronchitis and lung infection accelerate lung function decline
Source: Research Seminar 2021 – Lung function trajectories from birth to death, health and disease, and pre-war to today
Year: 2021
COPD is associated with reduced pulmonary interstitial expression of pentraxin-3
Source: Eur Respir J 2012; 39: 830-838
Year: 2012
Is lung emphysema in COPD patients reflected by central airways inflammation?
Source: Eur Respir J 2003; 22: Suppl. 45, 207s
Year: 2003
Assessment of innate immunity mediators in the lung of COPD patients: relation with disease manifestations
Source: Virtual Congress 2020 – Host-microbe interactions and their influence on lung disease onset and severity
Year: 2020
The impact of bacterial colonisation on airway inflammation in stable COPD
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012
The pulmonary microbiome in sarcoidosis is similar to other parenchymal lung diseases
Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Year: 2018
IL-17A from innate and adaptive lymphocytes contributes to inflammation and damage in cystic fibrosis lung disease
Source: Eur Respir J, 57 (6) 1900716; 10.1183/13993003.00716-2019
Year: 2021
Short-term dynamic lung function and predictors of lung function decline in systemic sclerosis-related interstitial lung disease
Source: Virtual Congress 2020 – Diagnostic and prognostic markers for disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept